www.fdanews.com/articles/154138-watson-8217-s-former-hq-gets-483-for-deviation-investigation-shortfalls

Watson’s Former HQ Gets 483 for Deviation Investigation Shortfalls

March 22, 2013

Watson Laboratories, now known as Actavis, received a Form 483 for deviation investigation shortfalls at a facility located on the site of the company’s former Corona, Calif., headquarters.
Drug GMP Report